Polyethylenimine-functionalized fibroin nanoparticles as a potential oral delivery system for BCS class-IV drugs, a case study of furosemide
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Silk-based biomaterials and applications · RNA Interference and Gene Delivery · Biochemical and Structural Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Date AA, Hanes J, Ensign LM (2016) Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release 240:504–526. https://doi.org/10.1016/j.jconrel.2016.06.01610.1016/j.jconrel.2016.06.016 ↗
2. Pham DT, Tiyaboonchai W (2021) Fibroin-coated poly(ethylenimine)-docusate nanoparticles as a novel drug delivery system. Curr Sci 121:775–780. https://doi.org/10.18520/CS/V121/I6/775-78010.18520/CS/V121/I6/775-780 ↗
3. Pham DT, Tetyczka C, Hartl S et al (2020) Comprehensive investigations of fibroin and poly(ethylenimine) functionalized fibroin nanoparticles for ulcerative colitis treatment. J Drug Deliv Sci Technol 57:101484. https://doi.org/10.1016/J.JDDST.2019.10148410.1016/J.JDDST.2019.101484 ↗
4. Pham DT, Thao NTP, Thuy BTP et al (2022) Silk fibroin hydrogel containing Sesbania sesban L. extract for rheumatoid arthritis treatment. Drug Deliv 29:882–888. https://doi.org/10.1080/10717544.2022.205084810.1080/10717544.2022.2050848 ↗
5. Pham DT, Tiyaboonchai W (2020) Fibroin nanoparticles: a promising drug delivery system. Drug Deliv. https://doi.org/10.1080/10717544.2020.173620810.1080/10717544.2020.1736208 ↗
6. Pham DT, Saelim N, Tiyaboonchai W (2019) Alpha mangostin loaded crosslinked silk fibroin-based nanoparticles for cancer chemotherapy. Colloids Surf B Biointerfaces 181:705–713. https://doi.org/10.1016/J.COLSURFB.2019.06.01110.1016/J.COLSURFB.2019.06.011 ↗
7. Wu P, Liu Q, Li R et al (2013) Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. ACS Appl Mater Interfaces. https://doi.org/10.1021/am403992b10.1021/am403992b ↗
8. Moin A, Wani SUD, Osmani RA et al (2021) Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer. Drug Deliv 28:1626–1636. https://doi.org/10.1080/10717544.2021.195810610.1080/10717544.2021.1958106 ↗
9. Pham DT, Saelim N, Tiyaboonchai W (2020) Paclitaxel loaded EDC-crosslinked fibroin nanoparticles: a potential approach for colon cancer treatment. Drug Deliv Transl Res 10:413–424. https://doi.org/10.1007/S13346-019-00682-710.1007/S13346-019-00682-7 ↗
10. Crivelli B, Bari E, Perteghella S et al (2019) Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. Eur J Pharm Biopharm 137:37–45. https://doi.org/10.1016/j.ejpb.2019.02.00810.1016/j.ejpb.2019.02.008 ↗
11. Dyakonov T, Yang CH, Bush D et al (2012) Design and Characterization of a silk-fibroin-based drug delivery platform using naproxen as a model drug. J Drug Deliv 2012:490514. https://doi.org/10.1155/2012/49051410.1155/2012/490514 ↗
12. Li J, Khalid A, Verma R et al (2021) Silk fibroin coated magnesium oxide nanospheres: a biocompatible and biodegradable tool for noninvasive bioimaging applications. Nanomaterials 11:695. https://doi.org/10.3390/NANO1103069510.3390/NANO11030695 ↗
13. Pham DT, Ha TKQ, Nguyen MQ et al (2022) Silk fibroin nanoparticles as a versatile oral delivery system for drugs of different biopharmaceutics classification system (BCS) classes: a comprehensive comparison. J Mater Res 37:4169–4181. https://doi.org/10.1557/S43578-022-00782-010.1557/S43578-022-00782-0 ↗
14. Brooks AE (2015) The potential of silk and silk-like proteins as natural mucoadhesive biopolymers for controlled drug delivery. Front Chem 3:65. https://doi.org/10.3389/FCHEM.2015.00065/BIBTEX10.3389/FCHEM.2015.00065/BIBTEX ↗
15. Koperska MA, Pawcenis D, Milczarek JM et al (2015) Fibroin degradation–critical evaluation of conventional analytical methods. Polym Degrad Stab 120:357–367. https://doi.org/10.1016/J.POLYMDEGRADSTAB.2015.07.00610.1016/J.POLYMDEGRADSTAB.2015.07.006 ↗
16. Pham DT, Saelim N, Tiyaboonchai W (2018) Crosslinked fibroin nanoparticles using EDC or PEI for drug delivery: physicochemical properties, crystallinity and structure. J Mater Sci 53:14087–14103. https://doi.org/10.1007/S10853-018-2635-310.1007/S10853-018-2635-3 ↗
17. Pham DT, Saelim N, Cornu R et al (2020) Crosslinked fibroin nanoparticles: investigations on biostability, cytotoxicity, and cellular internalization. Pharmaceuticals (Basel) 13:86. https://doi.org/10.3390/ph1305008610.3390/ph13050086 ↗
18. Boles Ponto LL, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (part II). Clin Pharmacokinet 18:460–471. https://doi.org/10.2165/00003088-199018060-0000310.2165/00003088-199018060-00003 ↗
19. Boles Ponto LL, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). Clin Pharmacokinet 18:381–408. https://doi.org/10.2165/00003088-199018050-0000410.2165/00003088-199018050-00004 ↗
20. Shin SC, Kim J (2003) Physicochemical characterization of solid dispersion of furosemide with TPGS. Int J Pharm 251:79–84. https://doi.org/10.1016/S0378-5173(02)00586-010.1016/S0378-5173(02)00586-0 ↗
21. Rwobotham PC, Stanford JB, Sugden JK (1976) Some aspects of the photochemical degradation of frusemide. Pharm Acta Helv 51(10):304–307. https://doi.org/10.1002/CHIN.19770810810.1002/CHIN.197708108 ↗
22. Bhat NV, Nadiger GS (1980) Crystallinity in silk fibers: partial acid hydrolysis and related studies. J Appl Polym Sci 25:921–932. https://doi.org/10.1002/APP.1980.07025051810.1002/APP.1980.070250518 ↗
23. Cebe P, Partlow BP, Kaplan DL et al (2017) Silk I and silk II studied by fast scanning calorimetry. Acta Biomater 55:323–332. https://doi.org/10.1016/J.ACTBIO.2017.04.00110.1016/J.ACTBIO.2017.04.001 ↗
24. Kamalha E, Zheng Y, Zeng Y (2012) Analysis of the secondary crystalline structure of regenerated Bombyx mori fibroin. Res Rev Biosci 23:29
25. Um IC, Kweon HY, Park YH, Hudson S (2001) Structural characteristics and properties of the regenerated silk fibroin prepared from formic acid. Int J Biol Macromol 29:91–97. https://doi.org/10.1016/S0141-8130(01)00159-310.1016/S0141-8130(01)00159-3 ↗
26. Bayraktar O, Malay Ö, Özgarip Y, Batigün A (2005) Silk fibroin as a novel coating material for controlled release of theophylline. Eur J Pharm Biopharm 60:373–381. https://doi.org/10.1016/J.EJPB.2005.02.00210.1016/J.EJPB.2005.02.002 ↗
27. Pham DT, Saelim N, Tiyaboonchai W (2019) Alpha mangostin loaded crosslinked silk fibroin-based nanoparticles for cancer chemotherapy. Colloids Surf B Biointerfaces 181:705–713. https://doi.org/10.1016/j.colsurfb.2019.06.01110.1016/j.colsurfb.2019.06.011 ↗
28. Burra S, Library SG-SR (2010) Enhancement of solubility and dissolution rate of frusemide through liquisolid technique. Sch Res Libr 2:321–328
29. Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 7:5577–5591. https://doi.org/10.2147/IJN.S3611110.2147/IJN.S36111 ↗
30. Jeong H, Hwang J, Lee H et al (2017) In vitro blood cell viability profiling of polymers used in molecular assembly. Sci Rep 7:9481. https://doi.org/10.1038/s41598-017-10169-510.1038/s41598-017-10169-5 ↗
31. Jiang G, Min SH, Oh EJ, Hahn SK (2007) DNA/PEI/Alginate polyplex as an efficient in vivo gene delivery system. Biotechnol Bioprocess Eng 12:684–689. https://doi.org/10.1007/BF0293108610.1007/BF02931086 ↗
32. Pollard H, Remy JS, Loussouarn G et al (1998) Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 273:7507–7511. https://doi.org/10.1074/JBC.273.13.750710.1074/JBC.273.13.7507 ↗
33. Baker A, Saltik M, Lehrmann H et al (1997) Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 4:773–782. https://doi.org/10.1038/SJ.GT.330047110.1038/SJ.GT.3300471 ↗
34. Nguyen NNT, Pham DT, Nguyen DT, Trinh TTL (2021) Bilayer tablets with sustained-release metformin and immediate-release sitagliptin: preparation and in vitro/in vivo evaluation. J Pharm Investig 51:579–586. https://doi.org/10.1007/S40005-021-00533-Z10.1007/S40005-021-00533-Z ↗
35. Bundgaard H, Nørgaard T, Nielsen NM (1988) Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int J Pharm 42:217–224. https://doi.org/10.1016/0378-5173(88)90178-010.1016/0378-5173(88)90178-0 ↗
36. Demeneix B, Behr JP (2005) Polyethylenimine (PEI). Adv Genet 53:215–230. https://doi.org/10.1016/S0065-2660(05)53008-610.1016/S0065-2660(05)53008-6 ↗
37. Dey D, Inayathullah M, Lee AS et al (2011) Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid. Biomaterials 32:4647–4658. https://doi.org/10.1016/J.BIOMATERIALS.2011.03.01610.1016/J.BIOMATERIALS.2011.03.016 ↗
38. Diebold SS, Kursa M, Wagner E et al (1999) Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells*. J Biol Chem 274:19087–19094. https://doi.org/10.1074/JBC.274.27.1908710.1074/JBC.274.27.19087 ↗